Hospital Pharmacy Europe

OCTOBER 14, 2024

The idea of cancer vaccines is not new, but Dr Victoria Kunene, consultant medical oncologist at Queen Elizabeth Hospital Birmingham, UK, is leading the charge in their latest iteration: personalised preventative and therapeutic mRNA vaccines against colorectal cancer.

Vaccines 52

Vaccines Chemotherapy Hospitals Immunization 52

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunization Documentation 111

pharmaphorum

OCTOBER 12, 2022

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Similar to how we injected mRNA into people to trigger an immune response and train their immune system against COVID-19, genomic medicine repairs cellular or molecular mechanisms that are dysfunctional and cause disease.”.

Immunization 105

Immunization Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

MAY 26, 2023

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. was powered by the advent of immune-checkpoint inhibitors, added Chalk.

Immunization 105

Immunization Vaccines Compounding Insurance 105

Hospital Pharmacy Europe

FEBRUARY 16, 2023

The body’s innate immune system is designed to provide the first line of defence against microbial pathogens and which is achieved via the use of Toll-like receptors (TLR), i.e., microbe recognition receptors present on the surface of cells.

Immunization 52

Immunization Hospitals Vaccines 52

PharmaShots

MARCH 14, 2023

The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. UniQure’s Glybera is the first approved gene therapy by the EMA in the year 2012 for the treatment of a rare disease lipoprotein lipase deficiency.

FDA 40

FDA Immunization Compounding Vaccines 40

PharmaShots

APRIL 25, 2023

Founded Year: 2012 Total Employees: ~190 Headquarters: California, United States Market Cap: $1.2B Through its internal development, partnerships, and acquisitions, the company has put together four technology platforms that primarily focus on antibodies, T cells, innate immunity, and siRNAs. R&D Expenditure: $150.4M

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Packaging Immunization Vaccines 40